Cyclacel Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -1.8 | -100% |
| P/S |
|
34.42 | 33.58 | 2.49% |
|
|
| P/BV |
|
23.81 | 4.79 | 396.93% |
|
|
| P/FCF |
|
0 | 60.06 | -100% |
|
|
| Ev/Ebitda |
|
-0.3672 | -17.26 | -97.87% |
|
|
| Ev/S |
|
26.46 | 22.49 | 17.68% |
|
|
| Ev/FCF |
|
-0.6896 | 67.63 | -101.02% |
|
|
| E/P |
|
0 | 0.0168 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-7206.67 | -12.31 | 58466.93% | -41678.57 | -82.71% |
| ROE |
|
-3715.82 | 9.39 | -39666.48% |
|
|
| ROA |
|
-256.16 | 0.1519 | -168710.9% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-5370.24 | -25.64 | 20844.23% |
|
|
| ROCE |
|
-4991.6 | 14.76 | -33923.25% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0012 | -3.68 | -99.97% | -0.0018 | -32.14% |
| Nеt Debt/Ebitda |
|
0.1104 | -4.07 | -102.71% |
|
|
| Debt/Ratio |
|
0.0042 | 0.199 | -97.89% |
|
|
| Debt/Equity |
|
0 | 1.67 | -100% |
|
|
| Debt/Net Income |
|
-0.0016 | 10.34 | -100.02% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.48/10
|
2.99 | 0.5399 | 453.82% | 5.02 | -40.41% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0.8571 | 0.2331 | 267.74% |
|
|
| Average dividend growth |
|
-25 | 1.07 | -2446.28% |
|
|
| Average percentage for 5 years |
|
5.02 | 0.4916 | 920.56% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
2.45 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-50.18 | 76.2 | -165.85% | ||
| Growth impulse Ebitda in 5 years |
|
159.41 | 44.75 | 256.22% | ||
| Growth impulse Net Income in 5 years |
|
189.17 | -15.36 | -1331.58% | ||
| Growth impulse FCF in 5 years |
|
69.66 | -9.39 | -841.85% | ||
| Growth impulse EPS in 5 years |
|
5522790.8 | -84.03 | -6572503.67% |
IP Score
5.25/10
